Loading insider details...
Beta
Latest Form 4 (Jun 9, 2026): Grant/Award of 13,000 CRSP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Feb 13, 2026 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Grant/Award | 4,981 | n/a |
| Jun 6, 2025 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| May 19, 2025 | Discover Financial Services (DFS) | Disposition to Issuer | 79,943 | n/a |
| Feb 28, 2025 | CRISPR Therapeutics AG (CRSP) | Purchase | 7,000 | $313.9K |
| Feb 4, 2025 | Discover Financial Services (DFS) | Tax Withholding | 1,840 | $370.0K |
| Jan 27, 2025 | Discover Financial Services (DFS) | Grant/Award | 14,630 | n/a |
| Dec 23, 2024 | Discover Financial Services (DFS) | Grant/Award | 12,109 | n/a |
| May 31, 2024 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Feb 26, 2024 | Discover Financial Services (DFS) | Grant/Award | 29,324 | n/a |